Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InnovAge Holding Corp INNV

Healthcare Drug Manufacturers - Major
InnovAge Holding Corp. is a healthcare delivery platform. The Company is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly... see more

Recent & Breaking News (NDAQ:INNV)

Innovus Pharma Signs Exclusive $2.6 Million Dollar Marketing and Distribution Agreement with Khandelwal Laboratories to Market and Distribute Zestra(R) EjectDelay(R) Sensum+(R) and Zestra Glide(R) for the Indian Subcontinent

Accesswire September 10, 2015

Innovus Pharmaceuticals Announces First Commercial Shipment of EjectDelay(R) (Uxor(R)(TM)) to Canada

Accesswire September 3, 2015

Innovus Pharmaceuticals Announces First Commercial Shipment of EjectDelay(R) (Uxor(R)(TM)) to Canada

Accesswire September 3, 2015

Innovus Pharma Announces Closing of $500,000 Tranche of Potential $1,500,000 Financing From Institutional Investors

Accesswire August 3, 2015

Innovus Pharma Announces Closing of $500,000 Tranche of Potential $1,500,000 Financing From Institutional Investors

Accesswire August 3, 2015

Innovus Pharma Announces Positive Regulatory Guidance from Europe to File for Zestra(R) as Herbal Medicine

Accesswire July 23, 2015

Innovus Pharma Announces Positive Regulatory Guidance from Europe to File for Zestra(R) as Herbal Medicine

Accesswire July 23, 2015

Innovus Pharma Signs Exclusive License and Distribution Agreement with Elis Pharmaceuticals for Zestra(R), Zestra Glide(R), EjectDelay(R), Sensum+(R) and Vesele(R) in Turkey and Select African and Gulf Countries

Accesswire July 7, 2015

Orimed, Innovus Pharma (OTCQB: INNV) Partner, Announces the Availability of Zestra(R) and UXOR(TM) in Canadian Pharmacies in the Summer of 2015 with Over 225,000 Doses

Accesswire July 2, 2015

Innovus Pharmaceutical Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder

Accesswire July 1, 2015

Innovus Pharmaceutical's Release Results Indicating Vesele(R) Achieves 58% Increase in Sexual Desire in Women

Accesswire June 18, 2015

Innovus Pharmaceutical's Release Results Indicating Vesele(R) Achieves 58% Increase in Sexual Desire in Women

Accesswire June 18, 2015

New Equity Network Radio Show Features FlutiCare(TM), Innovus Pharma's Product for Allergic Rhinitis in an Exclusive Interview with President and CEO Dr. Bassam Damaj

Accesswire June 10, 2015

Innovus Pharmaceuticals Announces Successful Top Line Results from Vesele(R) in Erectile Dysfunction Accompanying Endpoints

Accesswire June 5, 2015

Innovus Pharmaceuticals Establishes over 36,000 Retail Stores as Vendors of Record for its FlutiCare(TM) Product in the US

Accesswire June 2, 2015

Innovus Pharmaceuticals to Present at the 2015 Marcum Microcap Conference

Accesswire May 22, 2015

Innovus Pharmaceuticals Expands Online and Catalogue Distribution in the U.S. for its Products

Accesswire May 20, 2015

Innovus Pharmaceuticals Announces Shipment of First Commercial Sensum+ Product to Its Partner in the United Kingdom

Accesswire May 18, 2015

Innovus Pharmaceuticals Announces the Official Launch of Sensum+(R) in Morocco by its Partner Ovation Pharma with an Initial Order of Approximately 240,000 Doses

Accesswire May 12, 2015

SeeThruEquity Issues Update on Innovus Pharmaceuticals and Maintains Target Price of $1.34

Accesswire April 27, 2015